Preclinical studies using native GLP-1 or GLP-1RA have provided convincing evidence of its cardioprotective benefits, while clinical trials have shown positive effects on hypertension and dyslipidemia in patients with T2DM [3]
In response to the UK regulator's warning, 'Novo Nordisk', the manufacturer of Wegovy and Ozempic, stated, "We recommend that patients only use these medications for their approved indications and under the strict supervision of a healthcare professional." 'Eli Lilly', the manufacturer of Mounjaro, said, "The Mounjaro patient information leaflet specifies that acute pancreatitis is an uncommon side effect that may affect up to 1 in 100 people." The MHRA plans to conduct a separate study on patients using GLP-1 class drugs
TB-500 is less inherently acid-stable
Melatonin effects on sleep are the most well-known
Team, Editorial
If someone becomes pregnant while taking a GLP-1 medication, the most important step is to contact their healthcare provider quickly, clinicians often advise in reproductive health guidance shared with patients